Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery

Current Pharmaceutical Design

Volumn 18, Issue 38, 2012, Pages 6204-6214

  Abdelmalak, Basem ^a   Ibrahim, Michael ^b   Yared, Jean Pierre ^a   Modic, Mary Beth ^a   Nasr, Christian ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Internal Medicine Resident at The Wright Center Regional Hospital of Scranton   (United States)

Author keywords

Anesthesia; Diabetes; Glucose control; Insulin pumps; Perioperative

Indexed keywords

ASPARTAME; FATTY ACID; GLUCOSE; GLYCEROL; INSULIN ASPART; INSULIN GLULISINE; INSULIN LISPRO; KETONE BODY; TRIACYLGLYCEROL;

ALGORITHM; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIET RESTRICTION; ELECTRONIC MEDICAL RECORD; FOOD AND DRUG ADMINISTRATION; GENERAL ANESTHESIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; MAGNETIC FIELD; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTANESTHESIA CARE; PRIORITY JOURNAL;

ALGORITHMS; BLOOD GLUCOSE; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS;

EID: 84873944879     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803832371     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed March 13, 2011.
2. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119-31.
3. Moitra VK, Meiler SE. The diabetic surgical patient. Curr Opin Anaesthesiol 2006; 19: 339-45.
4. Pickup JC, Renard E. Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 2008; 31 (Suppl 2): S140-5.
5. Bode BW. Insulin pump use in type 2 diabetes. Diabetes Technol Ther 2010; 12 (Suppl 1): S17-21.
6. Bailon RM, Partlow BJ, Miller-Cage V, et al. Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients. Endocr Pract 2009; 15: 24-9.
7. New generation of insulin pump-Starbridge secures global diabetes contract. Medical News Today, November 19, 2005. Available at www.medicalnewstoday.com/releases/33847.php [Accessed April 24, 2011].
8. U.S. Food and Drug Administration. General Hospital and Personal Use Medical Devices Panel. Insulin Infusion Pumps Panel Information. March 5, 2010.
9. Grunberger G, Bailey TS, Cohen AJ, et al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract 2010; 16: 746-62.
10. Nassar AA, Partlow BJ, Boyle ME, Castro JC, Bourgeois PB, Cook CB. Outpatient-to-inpatient transition of insulin pump therapy: successes and continuing challenges. J Diabetes Sci Technol 2010; 4: 863-72.
11. Ferrari LR. New insulin analogues and insulin delivery devices for the perioperative management of diabetic patients. Curr Opin Anaesthesiol 2008; 21: 401-5.
12. Cook CB, Boyle ME, Cisar NS, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: proposed guidelines and outcome measures. Diabetes Educ 2005; 31: 849-57.
13. Scheiner G, Sobel RJ, Smith DE, et al. Insulin pump therapy: guidelines for successful outcomes. Diabetes Educ 2009; 35 (Suppl 2): 29S-41S; quiz 28S, 42S-3.
14. Bevier WC, Zisser H, Palerm CC, et al. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique. Diabetes Metab Res Rev 2007; 23: 472-8.
15. Guilhem I, Balkau B, Lecordier F, et al. Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia 2009; 52: 2662-4.
16. Amodio A. Insulin Pumps: The Basics (blog post). Available at: http://health.families.com/blog/insulin-pumps-the-basics. [Accessed January 28, 2011].
17. Pryce R. Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight. BMJ 2009; 338: a2218.
18. Insulin Pump Therapy. Available at http://www.medtronic.com/forhealthcare-professionals/products-therapies/diabetes/therapies/insulin-pump-therapy/patient-selection/index.htm [Accessed March 4, 2011].
19. Medtronic. Indications, Safety, and Warnings Medtronic Diabetes Insulin Infusion Pumps. Available at http://www.medtronic.com/for-healthcare-professionals/products-therapies/diabetes/therapies/insulin-pump-therapy/indications-safety-warnings/index/htm [Accessed April 23, 2011].
20. Halperin H, Stevenson R. Band stop filter employing a capacitor and an inductor tank circuit to enhance mri compatibility of active medical devices. United States Patent Application. Assignee: Greatbatch Ltd., Clarence, NY. [Issue date: September 2, 2010].
21. Abdelmalak B, Maheshwari A, Mascha E, et al. Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major noncardiac surgery. BMC Anesthesiol 2010; 10: 11.
22. Abdelmalak B, Maheshwari A, Kovaci B, et al. Validation of the DeLiT Trial intravenous insulin infusion algorithm for intraoperative glucose control in noncardiac surgery: a randomized controlled trial. Can J Anesth 2011; 58(7): 606-16.
23. Hans P, Vanthuyne A, Dewandre PY, Brichant JF, Bonhomme V. Blood glucose concentration profile after 10 mg dexamethasone in nondiabetic and type 2 diabetic patients undergoing abdominal surgery. Br J Anaesth 2006; 97: 164-70.
24. Egi M, Bellomo R, Stachowski E, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011; 39: 105-11.
25. Standards of medical care in diabetes--2011. Diabetes Care 2011; 34 Suppl 1: S11-61
26. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-97.
27. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39.
28. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009; 35: 1738-48.
29. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008; 36: 3190-7.
30. Fahy BG, Sheehy AM, Coursin DB. Perioperative glucose control: What is enough? Anesthesiology 2009; 110: 204-6.
31. Schultz MJ, Royakkers AA, Levi M, Moeniralam HS, Spronk PE. Intensive insulin therapy in intensive care: an example of the struggle to implement evidence-based medicine. PLoS Med 2006; 3:e456.
32. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 2006; 15:370-7.
33. der Voort PH, Feenstra RA, Bakker AJ, Heide L. Boerma EC, van der Horst IC. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf) 2006; 64: 141-5.
34. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 2010; 137: 544-51.
35. Rice MJ, Coursin DB. Continuous measurement of glucose: facts and challenges. Anesthesiology 2012; 116(1): 199-204